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Regulatory T cells control the dynamic and site-specific
polarization of total CD4 T cells following Salmonella
infection
Slater L. Clay 1,2, Alberto Bravo-Blas1,3, Daniel M. Wall1, Megan K. L. MacLeod1 and Simon W. F. Milling1
FoxP3+ regulatory T cells (Tregs) control inflammation and maintain mucosal homeostasis, but their functions during infection are
poorly understood. Th1, Th2, and Th17 cells can be identified by master transcription factors (TFs) T-bet, GATA3, and RORγT; Tregs
also express these TFs. While T-bet+ Tregs can selectively suppress Th1 cells, it is unclear whether distinct Treg populations can alter
Th bias. To address this, we used Salmonella enterica serotype Typhimurium to induce nonlethal colitis. Following infection, we
observed an early colonic Th17 response within total CD4 T cells, followed by a Th1 bias. The early Th17 response, which contains
both Salmonella-specific and non-Salmonella-specific cells, parallels an increase in T-bet+ Tregs. Later, Th1 cells and RORγT+ Tregs
dominate. This reciprocal dynamic may indicate that Tregs selectively suppress Th cells, shaping the immune response. Treg
depletion 1–2 days post-infection shifted the early Th17 response to a Th1 bias; however, Treg depletion 6–7 days post-infection
abrogated the Th1 bias. Thus, Tregs are necessary for the early Th17 response, and for a maximal Th1 response later. These data
show that Tregs shape the overall tissue CD4 T cell response and highlight the potential for subpopulations of Tregs to be used in
targeted therapeutic approaches.
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INTRODUCTION
Salmonella enterica serovar Typhimurium (S. Tm) infects a wide
range of animals and is a common non-typhoidal Salmonella
serotype in humans. To study intestinal S. Tm infection, a
streptomycin pretreatment model has been developed, creating
a niche for S. Tm to colonize.1,2 This facilitates consistent intestinal
infection and colitis.3,4 Because the use of virulent S. Tm strains in
susceptible mice causes high mortality, we here combine
streptomycin pretreatment with an attenuated S. Tm strain that
induces consistent nonlethal colitis. This enabled analysis of the
CD4 T cell response in the colonic lamina propria and the draining
lymph nodes.
CD4 T helper (Th) cells drive intestinal immune responses and
can express master transcription factors (TFs). T-bet, GATA3, and
RORγT are used to identify Th1, Th2, and Th17 cells, respectively.
CD4 T cells are critical for both clearance of S. Tm infection and
protection from reinfection.5,6 In particular, Th1 cells are required
for S. Tm clearance and protective immunity in systemic
infection.5,7–9 In addition to Th1 cells, an early Th17 response
has been identified in the intestines, which is important for
limiting epithelial damage and systemic dissemination.10–12 Thus,
an effective immune response to S. Tm involves both Th17 and
Th1 cells. It is unclear however, how the balance between these
responses is controlled.
FoxP3+ regulatory T cells (Tregs) regulate conventional T cells
(Tconvs) and control the CD4 T cell response during infection.13–15
Tregs can differentiate in the thymus (tTregs) or peripheral tissue
(pTregs). While both tTregs and pTregs are found in the
intestines,16–18 their contribution to immune responses to
infection is poorly characterized. In addition to FoxP3, Tregs can
express Th master TFs T-bet, RORγT, or GATA3.19–22 The role of
these Treg TFs is the subject of ongoing research and accumulat-
ing evidence suggests that Tregs expressing Th TFs may
selectively suppress their respective Th subset.21,23,24 T-bet+ Tregs
can selectively target Th1 cells, but it is unclear whether Tregs
expressing other TFs have similarly selective functions.21,24 It is
also unclear whether selective suppression can alter the balance
of Th cell responses during infection.
To investigate the role of Tregs in controlling the CD4 T cell
response, we employed a model of S. Tm colitis with an
attenuated strain allowing identification of an S. Tm-specific T
cell clonotype. Characterization of Tconvs and Tregs highlighted a
dynamic colonic T cell response within total T cells at the infection
site. This is dominated initially by Th17 cells, followed by a
sustained Th1 response. Interestingly, we identified a reciprocal
dynamic between Tconvs and Tregs expressing the same TFs. This
reciprocity indicated that subpopulations of Tregs may selectively
suppress Th subsets. Treg depletion experiments were therefore
carried out using FoxP3DTR mice.25 Results show that Tregs are
necessary for the early Th17 response and contribute to the later
Th1 bias. Thus, Tregs not only inhibit CD4 T cells, but shape the T
cell response in a fine-tuned, tissue-specific manner.
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RESULTS
Salmonella infection with BRD509-2W1S causes nonlethal colitis
with transient weight loss and increased numbers of total and
2W1S-specific CD4 T cells
To investigate the CD4 T cell response to S. Tm in the intestines,
attenuated strain BRD509-2W1S was orally administered to C57BL/
6 mice 24 h following streptomycin treatment. Infection caused
nonlethal colitis and allowed identification of S. Tm-specific T cells.
Representative images of large intestines, including the cecum
and colon, are shown from infected (top) and uninfected (bottom)
animals 6 days post-infection (p.i.) (Fig. 1a). Infected tissues show
colonic shortening, edema, empty and shriveled caeca, and an
enlarged cecal patch (Fig. 1a, inset). Despite physical signs of
colitis, S. Tm-infected mice lost <5% of initial weight, which
recovered to levels of mock (PBS)-infected controls by 14 days p.i.
(Fig. 1b). To assess bacterial dissemination, intestinal and
lymphoid tissues were processed and plated. At day 6 p.i. S. Tm
CFUs were recovered from the colon, mesenteric lymph nodes
(MLN), Peyer’s patches (PP), and small intestine (SI); significantly
more CFUs were recovered from the colon and MLN than the SI
(Fig. 1c).
Next, changes in total cell numbers, CD4 T cells and FoxP3+
Tregs were enumerated in the colonic lamina propria (LP) (Fig. 1d)
and MLN (Fig. 1e) at days 6, 30, and 60 p.i. There was a significant
increase in the number of total cells, CD4 T cells and Tregs at day 6
p.i., and total cell numbers remained elevated until 60 days p.i.
(Fig. 1d). The number of total MLN cells also increased 6 days p.i.,
but this increase was resolved by day 30 p.i. Unlike in the colon,
there was no significant increase in the number of MLN CD4 T cells
or Tregs (Fig. 1e).
Infection with BRD509-2W1S allows identification of S. Tm-
specific T cells with 2W1S:I-Ab tetramers (Supplementary Fig. S1). In
the colon and cecum, 2W1S-specific cells comprise 5–10% of total
CD4 T cells (Fig. 1f, Supplementary Fig. S2), but are less frequent in
lymphoid tissues including MLNs (Fig. 1g, Supplementary Fig. S2).
Tracking 2W1S-specific CD4 T cells over time showed these cells
were detectable until at least 90 days p.i. (Fig. 1f, g). The large
number of Tconvs specific for 2W1S reflects the immunodomi-
nance of the peptide, as previously reported.25–28 The higher
number of 2W1S-specific T cells in the intestinal LP than the MLNs
is consistent with the hypothesis that these cells are accumulating
at barrier sites to protect against invasion from the intestinal
lumen, where the highest bacterial burden is present (Supple-
mentary Fig. S4a).
The MLN CD4 T cell response to Salmonella is constrained to
colon-draining MLNs
The higher bacterial burden and number of 2W1S-specific T cells
observed in the large intestine compared with the SI (Fig. 1c,
Supplementary Fig. S2b), led to the hypothesis that the MLN CD4
T cell response was focused in the colon and cecum draining
MLNs (cMLNs). This hypothesis is consistent with previous work
showing that different intestinal sites drain to specific MLNs29,30
(Supplementary Fig. S3a). With the aim of improving sensitivity of
detecting S. Tm responses in the MLNs, a comparison of CD4
T cells in the cMLNs and sMLNs was conducted. Results show that
cMLNs but not sMLNs contain an increased number of total cells,
CD4 T cells, CXCR3+ CD4 T cells, and 2W1S-specific T cells
following S. Tm infection (Supplementary Fig. S3b, c). Together,
these data show that the CD4 T cell response to S. Tm in the MLN
is restricted to the colon and cecum-draining lymph nodes.
Characterization of 2W1S-specific T cells
To investigate the CD4 T cell response to S. Tm infection we
initially examined the 2W1S-specific T cell response, and observed
that 2W1S-specific T cells homogenously display a Th1 phenotype
(Supplementary Fig. S4), consistent with previous reports.28,31,32 As
such, 2W1S-specific cells expressed T-bet but not RORγT or FoxP3,
up to and including 60 days p.i. (Supplementary Fig. S4a, b).
Cytokine profiling of 2W1S-specific cells confirms a Th1 pheno-
type, with cells expressing IFNγ but not IL17A (Supplementary
Fig. S4c, d). It has been previously shown that S. Tm-specific CD4
T cells comprise cells that recognize a wide range of peptides, and
both S. Tm-specific and non-S. Tm-specific “bystander” cells play
an important role in Salmonella clearance and protection from
reinfection.31,33–35 Because of the phenotypic homogeneity of
2W1S-specific cells and the importance of a heterogenous CD4 T
cell response to S. Tm, we next characterized changes in the total
CD4 T cell pool.
S. Tm infection induces an early colonic Th17 response followed
by a sustained Th1 response
In contrast to 2W1S-specific cells, total CD4 T cells comprise
heterogenous and dynamic populations of Th1 cells, Th17 cells,
and Tregs following S. Tm infection. To characterize bulk CD4
T cells, that includes a mixture of CD4 T cell responding to the
bacteria, potential bystander cells, and cells not involved in the
response, we analyzed activated Tconvs by transcription factor
(TF) and cytokine expression. Tconvs were identified as CD4 T cells
(gated as described in Fig. 1d) that are CD44hi and FoxP3- (Fig. 2a,
left). Tconvs were characterized by expression of T-bet, RORγT, and
GATA3 to identify putative Th1, Th17, and Th2 cells respectively.36
The number and proportion of cMLN (Fig. 2b) and colonic LP
(Fig. 2c) CD44hi Tconvs are plotted from mock (PBS)-infected mice
and S. Tm-infected mice examined at 6, 30, or 60 days p.i. In the
cMLN, there are increased numbers and proportions of Tconvs
that are T-bet+, RORγT+, and T-bet+RORγT+ cells at 6 days p.i.
(Fig. 2b). Numbers of Tconv subsets return to baseline levels by
day 30 p.i., except T-bet+ cells, which remain elevated until
60 days p.i. In the colonic LP there is an increased number of
Tconvs expressing T-bet, RORγT, or T-bet and RORγT 6 days p.i
(Fig. 2c, left). While T-bet+, RORγT+, and T-bet+RORγT+ cells
increase in number, the increase in RORγT+ cells is greater, leading
to an increased proportion of RORγT+ cells, and a decreased
proportion of T-bet+ and GATA3+ cells at day 6 (Fig. 2c, right). This
increase in RORγT+ Tconvs at day 6 p.i. is transient however, and
by day 30 a strong bias toward T-bet+ Tconvs is observed. In
summary, there is an initial colonic RORγT+ response which shifts
to a long-lasting T-bet+ response. This dynamic CD4 T cell
response is observed in the colonic mucosa but not in the cMLN.
Reciprocal dynamics between colonic Tconvs and Tregs
expressing the same TFs
Following characterization of Tconvs by TF, FoxP3+ Tregs were
assessed for expression of Th master TFs T-bet, RORγT, and GATA3
(Fig. 3a, b). The number and proportion of colon Tregs expressing
these TFs were plotted from mock (PBS)-infected mice or S. Tm-
infected mice examined at 6, 30, or 60 days p.i. (Fig. 3b). There was
an increased number of T-bet+ and T-bet+RORγT+ Tregs at 6 days
p.i., but no increase of RORγT+ or GATA3+ Tregs. Changes in
absolute numbers correspond with an increased proportion of T-
bet+ Tregs and a reduced proportion of RORγT+ Tregs at day 6 p.i.
While these proportional changes are partially resolved by day 60
p.i., the percentage of Tregs that are T-bet+ remain elevated while
the proportion of RORγT+ Tregs remain lower than mock-infected
controls (Fig. 3b, right).
Comparing the proportion of colonic Tconvs and Tregs
expressing T-bet or RORγT reveals a reciprocal dynamic between
populations expressing the same TF. The early decrease in the
proportion of T-bet+ Tconvs (Fig. 2c, right) occurs concurrently
with an increased proportion of T-bet+ Tregs (Fig. 3b, right).
Conversely, the transient increase in the proportion of RORγT+
Tconvs corresponds with transient decrease in the proportion of
RORγT+ Tregs.
To further investigate this reciprocity, a more detailed time-
course was carried out during the first 30 days p.i. In Fig. 3c, d, the
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proportions of Tregs that are T-bet+ or RORγT+ (black lines) are
overlaid with the proportion of Tconvs (gray lines) that express the
same TFs. These plots highlight a reciprocal dynamic in the colon
but not the cMLN. Furthermore, these data show that day 6 p.i. is
the peak of the colonic RORγT+ Tconv response and that the T-
bet+ Tconv bias is re-established by day 11 p.i (Fig. 3c). In summary,
the early RORγT+ Tconv response in the colon coincides with an
increased proportion of T-bet+ Tregs, and the later T-bet Tconv bias
coincides with an increased proportion of RORγT+ Tregs.
Cytokine profiling supports characterization of Th subsets by TF
Next, we assessed IFNγ and IL17A expression to determine
whether T-bet+ and RORγT+ Tconvs are bona fide Th1 and Th17
cells, as previously described.37,38 At days 6 and 11 p.i., CD4 T cell-
generated IFNγ is predominantly expressed by T-bet+ Tconvs, and
IL17A is predominantly expressed by RORγT+ Tconvs (Fig. 4a). The
proportion of RORγt+ Tconvs cells correlates with the proportion
of IL-17A+ cells and the proportion of T-bet+ Tconvs correlates
with IFNγ+ cells, in both the colon and MLN (Fig. 4b, c).
Furthermore, T-bet+ Tconvs predominantly produce IFNγ while
RORγT+ Tconvs produce IL17A (Fig. 4d). T-bet+RORγT+ double
positive cells are heterogenous in cytokine production and include
IFNγ+ (Th1), IL17A+ (Th17), and IFNγ+IL17A+ (Th1/17 “double
positive”) cells. IFNγ/IL17A double positive cells are proportionally
the smallest component, comprising <20% of T-bet+RORγT+
Tconvs in the colon (Fig. 4c). Together, these data support that T-
bet and RORγT are appropriate markers for Th1 and Th17 cells in
this model.
Effect of bacterial burden on T cell responses following S. Tm
infection
To understand how the presence of S. Tm affects changes in the T
cell response, we treated mice with antibiotics to clear the
infection. S. Tm is known to cause persistent infection in mice and
bacterial clearance requires prolonged treatment.28,39 We
employed a previously described enrofloxacin treatment from
day 5 to day 29 p.i.33 In untreated mice, S. Tm CFUs could be
recovered in luminal contents and the spleen at day 30 p.i.;
following treatment, CFUs could not be recovered from any sites
or tissue (Supplementary Fig. S5a). Treatment reduced the
proportion and number of tetramer+ T cells at day 30, although
the number of 2W1S-specific cells in treated animals remained
above levels observed at day 6 (Supplementary Fig. S5b, c).
Enrofloxacin treatment did not change the T-bet+ phenotype of
2W1S-specific cells (Supplementary Fig. S5d), but reduced the
proportion of Tbet+ Tconv and RORgT+ Tregs at day 30 p.i. This
indicates that S. Tm persistence contributes to the Th1 response,
but that the reciprocal dynamic between Tconvs and Tregs is
maintained even when bacteria are cleared (Supplementary
Fig. S5e, f).
Helioshi Tregs can co-express T-bet+ and GATA3+ but not RORγT
The reciprocal dynamic between Tregs and Tconvs raises
questions about the ontogeny and stability of Tregs that express
T-bet or RORγT. Helios expression has been proposed to
differentiate tTregs from pTregs,40 but this is controversial as
Helios expression has also been reported in pTregs.41–43 To assess
a
50.2 16.2 30.6 22.0 57.9 21.6 58.0 28.6
PBS Day 6 Day 30 Day 60Tconvs
CD
44
T-
be
t
T-bet T-bet +
RORγT
20.013.7 28.718.7 11.39.2 5.97.4
FoxP3 RORγT
RORγT GATA3
T-bet T-bet +
RORγT
RORγT GATA3 T-bet T-bet +
RORγT
RORγT GATA3
T-bet T-bet +
RORγT
RORγT GATA3
b % of MLN Tconvs# of MLN Tconvs
% of colonic Tconvs# of colonic Tconvs
106
105
104
103
106
105
104
103
# 
of
 C
D
44
hi
 C
D
4 
Tc
on
vs
# 
of
 C
D
44
hi
 C
D
4 
Tc
on
vs
%
 o
f C
D
44
hi
 C
D
4 
Tc
on
vs
%
 o
f C
D
44
hi
 C
D
4 
Tc
on
vs
20 PBS
15
Day 6
Day 30
10
60
40
20
0
Day 60
PBS
Day 6
Day 30
Day 60
5
0
c
Fig. 2 At day 6 p.i. the proportion of Tbet+ colonic Tconvs decreases while the proportion of RORyT+ Tconvs increases. a Representative
plots of colonic Tconvs (CD44hi FoxP3- CD4+ cells, gated left) stained for T-bet and RORγT, following S. Tm or mock (PBS) infection. b TF
expression by cMLN Tconvs, shown as absolute numbers (left) or proportions of Tconvs (right). c TF expression by colonic Tconvs, shown as
absolute numbers (left) or proportions of Tconvs (right). Means ± SEM are plotted (n= 3–6 animals/group) and are representative of three
independent experiments. Statistical significance calculated by one-way ANOVA with Tukey’s test for each TF. ns not significant; *p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001.
Regulatory T cells control the dynamic and site-specific polarization of. . .
SL Clay et al.
4
Mucosal Immunology _#####################_
whether Tregs expressing Th TFs co-express Helios, t-SNE plots
were generated from colon CD4 T cells 11 days after mock or S.
Tm infection (Fig. 5). Representative plots of total CD4 T cells
(Fig. 5a, left and center) and Tregs (Fig. 5a, right) are shown with
gates color-coded to identify corresponding populations. Over-
laying FoxP3+ Tregs (red), FoxP3-CD44hi Tconvs (blue), and
FoxP3-CD44lo naïve T cells (green) (Fig. 5a, left) reveals distinct
cluster of Tregs (red), Tconvs (blue), and naïve T cells (green),
respectively (Fig. 5b, left). Overlaying T-bet+ (light blue), RORγT+
(plum), T-bet+RORγT+ (dark blue), and GATA3+ (orange) cells
identifies Th1, Th17, and Th2 cells in the Tconv clusters, and T-
bet+, RORγT+, and GATA3+ Tregs (Fig. 5b, c, left). Following S. Tm
infection, the Th1 and T-bet+RORγT+ population are visibly
increased and the Th2 population is almost absent in the Tconv
cluster (Fig. 5b, c, left).
Finally, FoxP3+ Tregs were gated as Helioshi (dark purple),
Heliosint (pink), and Helioslo (lilac) populations (Fig. 5a, right).
Overlaying these populations reveals that Helioshi Tregs overlap
one lobe of the Treg cluster, while Helioslo/int Tregs overlay
another (Fig. 5b, c, right). RORγT+ Tregs are confined to Helioslo/int
cells, GATA3+ Tregs are primarily Helioshi cells, and Tbet+ Tregs
include cells with a range of Helios expression levels. The
proportion of Helioslo Tregs is reduced by infection but RORyT+
Tregs remain Helioslo/int cells (Fig. 5b, c). Therefore, while S. Tm
infection alters the proportion of different Treg populations, the
co-expression of Th TFs with Helios remains stable.
The nonoverlapping expression of Helios and RORγT is
consistent with previous work suggesting Helios is a marker of
tTregs40 and RORγT is a marker of pTregs.22,44 Defining cell
function or ontogeny by marker expression is fraught with
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difficulties and it is not clear that Helioshi Tregs are bona fide
tTregs. However, these data in Fig. 5b, c indicate that Tbet+ and
RORγT+ Tregs can be distinguished by Helios expression. In
support of this, recent work demonstrating distinct TCR profile
between Helioshi and Helioslo Tregs45 suggests that T-bet+ and
RORγT+ Tregs are distinct populations instead of different states of
differentiation.
Treg depletion alters the balance of Th1 and Th17 responses
following S. Tm infection
The reciprocal dynamic between Tregs and Tconvs during S. Tm
infection (Fig. 3) is consistent with the hypothesis that Tregs
expressing Th master TFs selectively target Th subsets and skew
the Th response. To determine whether Tregs shape the dynamic
Th response to S. Tm, Treg depletion experiments were conducted
using FoxP3DTR “DEpletion of REGulatory T cell” (DEREG) mice,
which allow ablation of FoxP3+ Tregs following treatment with
diphtheria toxin (DT).46 Tregs were efficiently depleted from the
peripheral blood and colon after 2 DT treatments on consecutive
days. Five days post-treatment there were ~67% fewer Tregs in
the blood, and ~90% fewer Tregs in the colon than in DT-treated
littermate controls (Supplementary Fig. S6a, b). Similar to C57BL/6
mice, Treg-replete DEREG mice exhibit an early Th17 response and
later Th1 bias following S. Tm infection, and T-bet+ and RORgT+
Tregs show the same reciprocal dynamic with Tconvs in both
strains (Supplementary Fig. S6d).
In the first depletion experiments, DEREG mice were DT-treated
day 1 and 2 p.i., with an endpoint at day 6 p.i. (Fig. 6a). There was
no significant difference in weight change between DEREG mice
and DTR- (Treg replete) littermates (Supplementary Fig. S7a) nor in
S. Tm CFUs recovered 6 days p.i. (Supplementary Fig. S7c). The
number of total colon cells remained unchanged (Fig. 6b) but
both the number of CD4 T cells (Supplementary Fig. S7d) and
CD44hi Tconvs (Fig. 6c) increased following Treg depletion.
Although the number of tetramer+ cells trended higher,
differences were insignificant (Supplementary Fig. S7e). The
increase in CD4 T cells was confined to T-bet+ Th1 cells and T-
bet+RORγT+ cells, while the number of RORγT+ Th17 cells
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remained unchanged (Fig. 6d). The increased number of Th1 cells
underlies a decreased proportion of Th17 cells and an increased
Th1 bias (Fig. 6d, Supplementary Fig. S7b). The decreased
proportion of Th17 cells and increased proportion of Th1 cells
following early Treg depletion is robust, also being observed when
data from three independent experiments are pooled (Supple-
mentary Fig. S7b). These pooled data show a colonic Th17 bias in
Treg-replete DTR- mice, while there is a Th1 bias in Treg-depleted
DEREG littermates (Supplementary Fig. S7b, right). These data
demonstrate that the Th17 bias at 6 days p.i. (Fig. 2b) is dependent
on Tregs, which have an increased proportion of T-bet+ cells at
this timepoint (Fig. 3c, Supplementary Fig. S6d).
Next, Treg depletion experiments were conducted to determine
if Tregs were also required to drive the Th1 bias that becomes
prominent by day 11 p.i. (Fig. 2b). DT was administered day 6–7 p.
i. and the endpoint was day 11 p.i. (Fig. 6e). As described following
earlier DT treatment, later Treg depletion did not cause a
significant difference in weight change (Supplementary Fig. S7f),
the number of S. Tm CFU (Supplementary Fig. S7h) nor the
number of total colon cells (Fig. 6f) between DEREG mice and DTR-
littermates. There was an increase in the number of CD4 T cells
(Supplementary Fig. S7i), CD44hi Tconvs (Fig. 6g) and tetramer+
2W1S-specific T cells (Supplementary Fig. S7j). There was also an
increased number of both colonic Th17 and Th1 cells (Fig. 6h, left)
but the increase in Th17 cells was greater, reflecting an increased
proportion of Th17 cells at day 11 p.i. (Fig. 6h, right). The increased
proportion of Th17 cells following Treg depletion is also observed
when data from three independent experiments are pooled
(Supplementary Fig. S7g). These pooled data show the Th1 bias in
Treg-replete mice at day 11 p.i. is abrogated following Treg
depletion (Supplementary Fig. S7b, right).
To confirm that these changes in Th bias reflect dysregulation of
the immune response to Salmonella, and not general dysregula-
tion following Treg depletion, we compared the effect of Treg
depletion in uninfected DEREG mice (Supplementary Fig. S6). Four
days after DT treatment there was no significant change in Th bias
between Treg-depleted DEREG mice and DTR− littermates
(Supplementary Fig. S6e,f). This contrasts with robust changes in
Th bias of Treg-depleted mice following S. Tm infection (Fig. 6d, h;
Supplementary Fig. S7b, g). This indicates Treg depletion does not
shift Th bias in the absence of S. Tm infection.
Taken together, these results demonstrate that Tregs are
required for both the early Th17 response and a maximal Th1-
bias at day 11 p.i. In Fig. 6i, a schematic diagram depicts the Th
response following S. Tm infection and the effects of Tregs to
shape the dynamic Th response.
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DISCUSSION
Here we have developed an S. Tm infection model to characterize
a dynamic CD4 T cell response. We observe an early colonic Th17
response corresponding with a decreased proportion of RORγT+
Tregs and a later, long-lasting Th1 response with a decreased
proportion of T-bet+ Tregs (Fig. 3b–d) within the total T cells at the
infection site. The early Th17 response described here is consistent
with work identifying an early expansion and contraction of
flagellin-specific Th17 cells in the intestine.33 The Th1 response to
S. Tm has been shown to be important for bacterial clearance and
protective immunity.5,8,9,47 The dynamic and site-specific Th
response may therefore be optimized to counter a multi-phase
infection with changing bacterial targets. However, the factors
that control this response are unclear.
The reciprocal dynamic we reveal between Tconvs and Tregs
expressing the same TFs is consistent with the hypothesis that
Th1 cells are being suppressed by T-bet+ Tregs and Th17 cells are
being targeted by RORγT+ Tregs later after infection. That this
dynamic occurs in the colon LP and not the cMLN suggests that
reciprocity between Tconvs and Tregs is manifested in the colon
itself. Selective suppression of Th1 and Th17 cells by Tregs
expressing T-bet or RORγT has been previously reported. Tregs
have been shown to upregulate T-bet in response to type 1
inflammation and T-bet+ Tregs are required to control Th1-
mediated inflammation.24 In the context of Listeria infection, it has
been shown that T-bet+ Tregs suppress Th1 cells and comprise a
stable population that proliferates rapidly during reinfection.21 It
has also been shown that specific intestinal bacteria induce
RORγT+ Tregs, which limit Th17-mediated colitis, and ablation of
Treg-specific STAT3 induces Th17 inflammation.22,23 Microbiota-
specific CD4 T cells have also been shown to be multi-functional
and highly plastic.48 Unlike previous research, here we have
characterized a dynamic Th response that is reciprocal to a Treg
response. This highlights the potential for Tregs to shape a multi-
phase CD4 T cell response in an orchestrated and fine-tuned
manner.
To assess the regulation of CD4 T cells, we first assessed
changes in S. Tm-specific 2W1S:I-Ab tetramer+ T cells. 2W1S-
specific cells maintained a Th1 phenotype in all tissues and
timepoints (Supplementary Fig. S4a–d), in contrast to changes in
the bulk CD4 T cell pool. Previous work shows an important role
for Tconvs that recognize a wide range of S. Tm peptides, as well
as non-S. Tm-specific non-cognate activated “bystander”
cells,31,33–35 which prompted our focus on the bulk CD4 T cells.
As such, tetramer-negative cells are likely a heterogenous
population including cells specific for multiple S. Tm and non-S.
Tm antigens. Future work delineating the roles of S. Tm-specific
and non-S. Tm specific cells could help elucidate both the
reciprocal dynamics reported here and the functions and
interactions of CD4 T cells with different antigen specificity. While
the antigen specificities of tetramer-negative CD4 T cells
described here are unknown, we show that S. Tm infection
drives clear changes in these populations, including increased
numbers of Tconvs and Tregs, and changes in their TF expression
(Figs. 1d, 2c).
To investigate whether Tregs are responsible for changes in Th
bias, Tregs were depleted at critical timepoints. Day 6 p.i. was
identified as a peak of the early Th17 response and day 11 p.i. was
identified as a timepoint where a Th1 bias was re-established
(Fig. 3d). For the day 6 experiment, Tregs were ablated during the
period when colonic Tregs are enriched for T-bet+ cells; for the
day 11 experiment, Tregs were ablated during the period when
Tregs comprise a higher proportion of RORγT+ cells (Fig. 3b, c,
Supplementary Fig. S6c).
At both timepoints Treg depletion increased the number of
colonic Tconvs (Fig. 6c, g), consistent with previous reports.49–52
Treg depletion did not significantly reduce the number of S. Tm
CFUs recovered (Supplementary Fig. S7c, h), in contrast to a
previous report of reduced bacterial load in DEREG animals
systemically-infected with virulent S. Tm.53 This discrepancy may
result from our use of an oral infection model with an attenuated
strain, instead of i.v.-infection with a virulent strain. Because the
bacterial burden is low in our model (Supplementary Fig. S5a),
ablation of Tregs and shifts in Th bias may not have significant
effects on clearance of the few remaining bacteria.
These experiments show that early Treg ablation leads to a
selective increase in Th1 cells and prevents the Th17 bias at day 6
p.i. (Fig. 6d, Supplementary Fig. S7b). On the other hand, later Treg
ablation leads to an increased number and proportion of Th17
cells and abrogation of the Th1 bias (Fig. 6h, Supplementary
Fig. S7g). As such, Tregs, which are enriched for T-bet+ cells at
early timepoints, are necessary for the early Th17 response. At
later timepoints, when Tregs contain an increased proportion of
RORγT+ cells, Tregs are required for a maximal Th1 bias at day 11
p.i. This indicates that the reciprocal dynamics described here are
not just correlative, but that Tregs actively shape the CD4 T cell
bias (Fig. 6i). These results are consistent with the hypothesis that
T-bet+ Tregs selectively suppress the early Th1 response and shift
the Tconv response towards a Th17 bias, while RORγT+ Tregs
inhibit Th17 cells, enhancing the later Th1 response. Future work
assessing the effect of selectively depleting Treg subsets will help
elucidate the extent to which the dynamic Th response is
controlled by selective suppression by Tregs expressing T-bet
or RORγT.
The potential for CD4 T cells to up- or down-regulate FoxP3
expression is an alternative mechanism that could underly
reciprocity between populations of Tconvs and Tregs expressing
the same TFs. Plasticity between regulatory and conventional CD4
T cells has been demonstrated in several contexts. For instance,
RORγT+ Tregs have been shown to downregulate FoxP3 in the
absence of IL-15 and become “ex-Tregs” that drive Th17-mediated
colitis.54 It has also been shown that Th1 cells have the potential
to upregulate FoxP3 to become T-bet+ Tregs.55,56 On the other
hand, evidence from lineage tracking models, transfers and
in vitro experiments suggest that T-bet+ Tregs are highly stable
and retain FoxP3 expression independent of environmental
conditions.21,57 Because of the stability of T-bet+ Tregs, plasticity
is a less convincing explanation of reciprocity at later phases of
infection. Furthermore, the potential for co-expression of Helios
with T-bet but not RORγT by Tregs suggests distinct ontogenies.
As such, selective suppression is a possible explanation for both
reciprocal dynamics and Treg-dependent Th dynamics, although
plasticity between populations of Tconvs or between Tconvs and
Tregs may also contribute. Future work using lineage-tracking
models and TCR profiling would help delineate the contribution of
plasticity between subpopulations.
This research reveals a dynamic Th response in the colon after S.
Tm infection and a reciprocal dynamic between Tconvs and Tregs
expressing the same TFs. Treg depletion experiments show that
the early colonic Th17 response and subsequent Th1 bias are
dependent on Tregs. In conclusion we highlight that Tregs not
only inhibit the Tconv response but shape the CD4 T cell response
in a highly nuanced, site-specific and time-dependent manner.
These results not only have implications for understanding how
the T cell response to S. Tm is controlled, but also for how
intestinal T cell responses are balanced during infection or
inflammation in general.
MATERIALS AND METHODS
Mouse strains
Male C57BL/6J mice were purchased from Envigo (Huntingdon,
UK) and housed in individually ventilated cages (IVCs) prior to
experimental procedures. FoxP3DTR/eGFP DEpletion of REGulatory T
cell (DEREG) mice were kindly provided by Prof. Mark Travis
(University of Manchester, UK) with permission from Prof. Tim
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Sparwasser (Medizinische Hochschule Hannover, Germany).
DEREG mice were maintained in IVCs. All mice were maintained
under specific pathogen-free (SPF) conditions at the University of
Glasgow Central Research Facility or Veterinary Research Facility
(Glasgow, UK). All procedures were conducted under licenses
issued by the UK Home Office under the Animals (Scientific
Procedures) Act of 1986 and approved by the University of
Glasgow Ethical Review Committee.
Salmonella strains and culture
S. Tm BRD509 and BRD509-2W1S were kindly provided by Prof.
Stephen McSorley (University of California, Davis, USA). 2W1S
strains express the 2W1S (EAWGALANWAVDSA) epitope in frame
with OmpC.25,28 S. Tm cultures were streaked out on Luria-Bertani
(LB) agar plates before culturing in LB broth for 5 h at 37 °C in an
incubator shaking at 180 rpm. Cultures were then back-diluted
1:10 before static culture at 37 °C overnight (O/N). Cultures were
then adjusted to an OD600 of 1.00, centrifuged at 5000 G for 10
min, and resuspended in sterile phosphate buffered saline (PBS) at
an estimated concentration of 1.0–1.5 × 109 CFU/ml. Following
infections, actual bacterial dosage was confirmed by plating serial
dilutions of S. Tm inocula onto LB agar plates.
In vivo infections
6–10 week old mice were pre-treated with 20 mg streptomycin
(Sigma-Aldrich, USA) suspended in 10 µl sterile PBS by oral gavage
24 h before S. Tm infection. Mice were infected by administration
of 100 µl of S. Tm inoculum or PBS by oral gavage. For infection
time-course experiments (Figs. 1d–f, 2b, c, 3b–d), control animals
were PBS (mock)-infected at the same time as S. Tm-infected
animals. At each timepoint, S. Tm- and mock (PBS)-infected
animals were analyzed. Mock infected controls from each time-
point are combined into single control groups shown in time-
course graphs.
Bacterial recovery
Single cell suspensions from tissues were pelleted by centrifuging
at 400 G for 5 min and resuspended in 0.1% Triton X-100 (Sigma-
Aldrich) in PBS and incubated at room temperature (RT) for 10
min. Samples were then washed and pelleted before being
resuspended in PBS, serially diluted and plated on MacConkey
agar No. 2 (ThermoFisher, UK) containing 5 µg/ml streptomycin
(Sigma-Aldrich) and incubated O/N at 37 °C before CFUs were
calculated. Bacteria were recovered from feces and cecal contents,
which were collected, aliquoted into 100 µg samples, homoge-
nized and serially diluted and plated on MacConkey agar plates as
described above.
Enrofloxacin treatment
Antibiotic treatment of S. Tm-infected mice was carried out by
adding enrofloxacin (Bayer, Germany) to drinking water at 2 mg/
ml. Enrofloxacin treatment was provided from day 5 to 29 p.i. and
water was replaced every 72 h.
Tissue harvest and processing
External fat, PP and cecal patches (CP) were removed from
intestinal samples and the remaining tissue was chopped and
washed in HBSS with 2 mM EDTA (Gibco, UK). Samples were then
incubated at 37 °C shaking at 205 rpm for 10 min, washed in EDTA
buffer and the process was repeated twice. EDTA incubations and
washes were repeated thrice before digestion. Digest enzyme
cocktails were prepared in complete RPMI media (RPMI 1640 with
100 µg/ml streptomycin, 100 U/m penicillin, 2 mM L-glutamine,
and 50 µm 2-Mercaptoethanol) with 10% FCS (all Gibco). Colon
and cecal tissue were digested in an enzyme cocktail of 0.45 mg/
ml collagenase V (Sigma-Aldrich), 0.65 mg/ml collagenase D
(Roche, Switzerland), 1.0 mg/ml dispase (Gibco) and 30 µg/ml
DNAse (Roche). Small intestines were digested with 0.5 mg/ml
collagenase V (Sigma-Aldrich). Tissues were incubated at 37 °C in
an incubator shaking at 205 rpm for 15–20min. Following digests,
samples were filtered through 100 µm filters, washed twice with
buffer (PBS with 2% FCS and 2mm EDTA) and filtered through a
40 µm filter.
Lymph nodes, PPs and CPs were washed in HBSS and chopped
into ~1mm pieces, passed through a 40 µm filter and suspended
in buffer. Spleens were cleaned and fat was removed before
passing through a 40 µm filter with FACS buffer. Samples were
suspended in Ammonium-Chloride-Potassium lysing buffer (Ther-
moFisher) for 3–5min on ice, before washing and resuspending in
FACS buffer.
Staining for flow cytometry
2W1S:I-Ab tetramer was kindly provided by the NIH tetramer core
facility (Atlanta, GA). Following infection with S. Tm-2W1S strains,
tissues were processed as described above. Samples were
transferred into 96 well round bottom plates and resuspended
in 25 µl of tetramer mix containing complete RPMI with 10% FCS,
7 µg/ml 2W1S:IAb tetramer, 20 µl/ml mouse serum, and 10 µl/ml Fc
block (CD16/32) (Biolegend, CA). Plates were incubated for 2 h at
37 °C. Following tetramer staining, samples were stained with
fixable viability dye at a 1 µl/ml in PBS. Next, antibodies for
extracellular markers were prepared at 1:100 or 1:200 dilutions in
FACS buffer, as specified in the list of antibodies used
(Supplementary Fig. S7). Surface staining was performed at 4 °C
for 30 min before washing and resuspension.
TF staining was carried out after cells were fixed using the
eBioscience FoxP3 transcription factor staining kit (ThermoFisher)
or BD Cytofix (BD Biosciences, Belgium) according to manufac-
turer’s instructions. Cells were fixed for 1 h at room temperature
(RT) in the dark before washing and resuspending in eBioscience
FoxP3 permeabilization buffer (PB) (ThermoFisher). Following
fixation, TF antibodies were diluted in PB at concentrations listed
in Supplementary Fig. S7, added to samples and incubated O/N
at 4 °C.
For cytokine staining, cells were treated with eBioscience cell
stimulation cocktail (ThermoFisher), containing phorbol 12-
myristate 13-acetate, ionomycin, brefeldin A, and monensin,
according to manufacturer instruction. Samples were then surface
stained and fixed with BD Cytofix (BD Biosciences) according to
manufacturer’s instructions and stained with cytokine antibodies
diluted for 2 h at RT. Following cytokine staining, cells were
washed and resuspended in FACS buffer.
Flow cytometry
Samples were analyzed using a BD LSR Fortessa analyzer or sorted
using a BD FACSAria IIu or III (BD Biosciences) at the Institute of
Infection, Immunity and Inflammation Flow Core Facility (Uni-
versity of Glasgow).
Regulatory T cell depletion
Diphtheria toxin (DT) (Sigma-Aldrich) was suspended in PBS at a
concentration of 10 µg/ml. DT was administered intraperitoneally
(IP) twice, at a 24 h interval, at a concentration equivalent to 30
ng/g mouse weight. DT was administered to DTR+ DEREG mice
and DTR ̄ littermates as Treg-replete controls.
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